U.S., EU clear manufacturing plant for Bavarian Nordic's monkeypox vaccine - ETHealthWorld

Bavarian has received orders for millions of doses from across the globe, including nearly 7 million vaccine doses this year and next to the United States.

Drugmaker Bavarian Nordic said U.S. and European regulators have approved the use of Jynneos vaccine doses made at the company's plant in Denmark as global efforts to tackle the monkeypox outbreak pi… [+1183 chars]

full article...